Search
for
Sort by
Research 331–360 of 1000+
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Mice with Alopecia, Osteoporosis, and Systemic Amyloidosis Due to Mutation in Zdhhc13, a Gene Coding for Palmitoyl Acyltransferase
- Beyond Expectations
- The Spectrum of Skin Disease Among Indian Children
- Adverse Cutaneous Reactions to Antipsychotics
- Treatment of Vitiligo With the 308-nm Xenon Chloride Excimer Laser
- Application of multiphoton microscopy in dermatological studies: A mini-review
- Cutaneous and Mucosal Manifestations Associated with Celiac Disease
- Extracellular Matrix as a Regulator of Epidermal Stem Cell Fate
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- The Functional Diversity of Epidermal Keratins Revealed by the Partial Rescue of the Keratin 14 Null Phenotype by Keratin 16
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Oral Retinoids in Dermatology
- Adverse Cutaneous Reactions to Mood Stabilizers
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond
- Cicatricial (Scarring) Alopecias
- SLE and Serum Complement: Causative, Concomitant or Coincidental?
- Acquired scalp alopecia. Part II: A review
- Dermatological symptoms and sexual abuse: a review and case reports
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- The Genetics of Human Skin Disease
- Thyroid hormone action on skin.
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- INTERFERONS IN DERMATOLOGY
- ADVANCES IN PSORIASIS THERAPY
- Erosive pustular dermatosis of the scalp: a multicentre study
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Dermatologic Reactions to Targeted Therapy
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III